Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-04

Clinical Trial Update: Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating alternate-day prednisone versus daily fish oil supplements for IgA nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fish oil
  • PREDNISONE (Prednisone)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: IgA Glomerulonephritis | Phase 2 | Status: COMPLETED